FELLOWSHIP IN THORACIC ONCOLOGY Explore the Fellowship in Thoracic Oncology with our practical-based Postgraduate Diploma Program. Designed for medical professionals seeking expertise in diagnostics, this course offers clinical training and expert guidance, equipping you with advanced skills in the diagnosis and treatment of thoracic cancers. Course Price ₹ 2,50,000 ₹2,00000 Buy Course Now Get Free Details For Course Batch starts on Jan to Dec/ May to June Course Duration 12 Months Multimodal Program Hybrid Mode & Clinical Attachment Flexible payment financing options available Program overview MGA Medical Global Academy’s Fellowship in Thoracic Oncology is an advanced clinical training program for healthcare professionals who are interested in gaining specialized knowledge and expertise in the diagnosis, treatment, and multidisciplinary management of thoracic cancers. The program provides comprehensive knowledge in lung cancer, esophageal cancer, mediastinal tumors, pleural malignancies, thoracic imaging, molecular oncology, immunotherapy, radiation oncology, thoracic surgery, and palliative care. Participants will receive clinical exposure to cutting-edge diagnostic techniques such as bronchoscopy, EBUS, PET-CT interpretation, molecular diagnostics and minimally invasive thoracic interventions. The fellowship also has a special interest in targeted therapies, precision oncology, robotic thoracic surgery, immuno-oncology, radiotherapy innovations and AI based thoracic imaging technologies. Learners are taught to have good clinical decision-making skills and the ability to manage patients with multidisciplinary tumor board discussions, supervised clinical exposure, case-based learning, and mentorship by experienced thoracic oncology specialists. International oncology standards are followed and a focus is placed on evidence-based cancer care, research innovation, patient safety, and personalized treatment planning in thoracic oncology. What Skills You Will Gain Knowledge of thoracic oncology, tumor biology, molecular pathways and principles of multidisciplinary management of cancer. Diagnostic and staging skills for thoracic malignancies including lung cancer, esophageal cancer, mediastinal tumors and pleural cancers. Thoracic imaging interpretation skills including CT chest, PET-CT, MRI and advanced radiological assessment skills. Bronchoscopy, endobronchial ultrasound (EBUS) and minimally invasive thoracic procedures in clinical training such as image-guided biopsy procedures. Experience in molecular diagnostics, genomic profiling, biomarker interpretation and precision medicine strategies for thoracic oncology. Knowledge of specific treatments, Immunotherapy, systemic therapies, and treatment side effects. Experience in thoracic surgical oncology with VATS, robotic assisted thoracic surgery (RATS), lobectomy, and management of mediastinal tumors. Advanced radiation oncology techniques knowledge: IGRT, adaptive radiotherapy, proton therapy, radiotherapy planning, SBRT. Multidisciplinary tumor board participation, evidence-based treatment planning and management of complex thoracic cancer cases skills. Exposure to palliation, airway management, management of pleural disease and supportive cancer therapy. Knowledge of clinical trials, oncology research methodology, AI use, radiomics and new innovations in thoracic cancer care. Improved communication, patient counselling, patient ethics, leadership and collaborative multidisciplinary care skills. Career Outcomes After the Fellowship At the end of this fellowship, doctors will be able to enhance their skills and career prospects in thoracic oncology and cancer treatment. Acquire a specialized knowledge in thoracic oncology, lung cancer care and multi-disciplinary cancer care. Function in oncology medical centers, thoracic surgery centers, cancer institutes, academic medical centers and high-tech diagnostic institutions. Improve knowledge in thoracic imaging, molecular oncology, bronchoscopy, immunotherapy and minimally invasive cancer interventions. Utilize real-world data to optimize patient outcomes in cancer diagnosis, precision medicine and personalized oncology care. Increase the opportunities for the fields of thoracic surgical oncology, radiation oncology, interventional pulmonary surgery, and palliative cancer care. Become a recognized professional in the field of thoracic cancer diagnosis, treatment planning and its use in the multidisciplinary management of cancer. Participate as part of a multidisciplinary cancer team with oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, and palliative care providers. Improve opportunities for academic teaching, thoracic oncology research, clinical trials and leadership in healthcare. Keep abreast of the latest developments in molecular oncology, AI-driven imaging, robotic thoracic surgery, targeted therapies and immuno-oncology breakthroughs. Expand continuing education in the rapidly changing field of thoracic oncology and precision cancer treatment. Download Brochure in Whatsapp What you’ll learn Foundations of Thoracic Oncology Diagnostic Evaluation Treatment Modalities Complications and Survivorship Research and Innovation Professional Development and Leadership Key Features Attending /Non-Attending Classes Clinical Training in Nearest Hospital/Clinics. Free Study Material with recorded lectures Best Faculties (Super Specialists) of India 5. Library Access & Question & Answer Session6. NAAC A+ University7. 1 Year of Mentorship8. Updated Curriculum Course Curriculum Foundations of Thoracic Oncology Tumour biology of thoracic malignancies (lung, oesophagus, mediastinum, pleura) Epidemiology, risk-factors, screening & prevention (including smoking, environmental exposures) Anatomy, physiology and pathology of thoracic organs & mediastinum TNM staging and classification systems specific to thoracic tumours Principles of multidisciplinary oncology care: role of medical oncology, radiation oncology, thoracic surgery, pulmonology, pathology, radiology Introduction to tumour biology, molecular drivers, and immune micro-environment Ethical, legal and patient-communication aspects in oncology practice Diagnostic Evaluation & Work-up Imaging modalities: CT chest, PET-CT, MRI, endobronchial ultrasound (EBUS), mediastinoscopy, thoracoscopy Bronchoscopy & endoscopic techniques: rigid, flexible, guided biopsies Pathology: histology of thoracic tumours, immunohistochemistry, molecular diagnostics (EGFR, ALK, ROS1, PD-L1, next-gen sequencing) Liquid biopsy & circulating tumour-DNA in thoracic oncology Pulmonary function testing, cardiopulmonary reserve assessment, mediastinal involvement evaluation Pre-operative assessment, anaesthetic risk evaluation, and multidisciplinary tumour board participation Clinical staging, functional staging, nutritional assessment & pre-habilitation Treatment Modalities in Thoracic Oncology Surgical management: thoracotomy, video-assisted thoracoscopic surgery (VATS), robotic thoracic surgery, lobectomy, pneumonectomy, segmentectomy, mediastinal mass removal; peri-operative care Radiation therapy: principle of thoracic irradiation, SABR/SBRT for early lung cancer, conformal & intensity-modulated RT, role in oesophageal cancer, prophylactic cranial irradiation for small-cell lung cancer Medical oncology: chemotherapy regimens in lung & oesophageal cancers, targeted therapies (EGFR, ALK, ROS1, BRAF, etc), immunotherapy (checkpoint inhibitors), combination therapies, management of adverse-effects Combined modality therapy: neoadjuvant and adjuvant therapy, concurrent chemoradiation for locally advanced disease, salvage treatments Interventional pulmonology & minimally-invasive techniques: stenting, debulking, pleurodesis, endobronchial therapies Palliative and supportive treatments: management of malignant pleural effusion, airway obstruction, bone metastases, pain control Precision Medicine & Molecular Oncology Fundamentals of cancer genomics and molecular pathways in thoracic malignancies Key molecular targets and their inhibitors (EGFR, ALK, ROS1, KRAS, MET, RET, NTRK, HER2) Comprehensive genomic profiling (CGP) and next-generation sequencing (NGS) interpretation Role of liquid biopsy in early detection, minimal residual